SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-034317
Filing Date
2024-11-12
Accepted
2024-11-12 07:30:12
Documents
16
Period of Report
2024-11-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20241111_8k.htm   iXBRL 8-K 22822
2 EXHIBIT 99.1 ex_745839.htm EX-99.1 115344
7 logo01.jpg GRAPHIC 17819
  Complete submission text file 0001437749-24-034317.txt   330701

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20241111.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20241111_def.xml EX-101.DEF 11425
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20241111_lab.xml EX-101.LAB 15311
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20241111_pre.xml EX-101.PRE 11585
18 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20241111_8k_htm.xml XML 2850
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671997 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 241443297
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)